Physician

Shadi Hassan Shahouri, MD

According to 2025 Medicare claims, Shadi Shahouri, MD (NPI: 1568457950) practices rheumatology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is ARTHRITIS AND RHEUMATOLOGY CLINICS OF KANSAS LLC (NPI: 1700881646; TIN: 431899877) and primary practice location at 67206-3405. Shahouri is affiliated with the Aledade 38 KS CHC MSSP Enhanced (ACO ID: A4546) and Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Shahouri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,019 traditional Medicare patients, billed 207,777 HCPCS/CPT codes, and received $2,263,726 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,426 prescription claims across 755 beneficiaries totaling $2,344,183 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 112 records totaling $47,074. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $936,384 to $2,344,183. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	804	114,764	$1,525,978
2016	904	138,696	$1,769,896
2017	948	147,062	$2,195,157
2018	929	154,284	$2,352,231
2019	939	157,229	$2,510,710
2020	857	160,846	$2,446,145
2021	851	156,795	$2,290,410
2022	768	144,618	$2,086,201
2023	875	160,579	$2,033,837
2024	1,019	207,777	$2,263,726

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	594	4,500	$936,384
2016	593	4,487	$1,066,232
2017	578	4,197	$1,178,198
2018	583	4,043	$1,486,257
2019	642	4,496	$1,606,798
2020	662	4,672	$1,526,823
2021	622	4,198	$1,630,163
2022	577	3,955	$1,564,339
2023	654	4,025	$1,953,482
2024	755	5,426	$2,344,183

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	624	1,438	$85
80053	Blood test, comprehensive group of blood chemicals	538	980	$10
36415	Insertion of needle into vein for collection of blood sample	566	895	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	523	953	$8
85652	Red blood cell sedimentation rate, to detect inflammation, automated	513	891	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	52	2,100	$509,804
Humira Pen	Adalimumab	49	1,372	$339,960
Enbrel Sureclick	Etanercept	41	1,150	$308,788
Skyrizi Pen	Risankizumab-Rzaa	11	812	$217,933
Rinvoq	Upadacitinib	32	960	$199,656

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	102	$7,928	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$39,146	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shadi Hassan Shahouri, MD?

Tedicare shows public-source Medicare data for Shadi Hassan Shahouri, MD (NPI 1568457950), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shadi Hassan Shahouri, MD have ACO affiliation data?

Shadi Hassan Shahouri, MD is shown with ACO affiliation data for Aledade 38 KS CHC MSSP Enhanced (MSSP, ACO ID A4546) and Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Shadi Hassan Shahouri, MD?

Shadi Hassan Shahouri, MD is linked to ARTHRITIS AND RHEUMATOLOGY CLINICS OF KANSAS LLC (billing NPI 1700881646) in the available physician profile data.

Does Shadi Hassan Shahouri, MD have Open Payments data?

Shadi Hassan Shahouri, MD has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.